Preclinical research at BYU may lead to development of low-cost immunotherapy
General Utah
Archived
•
November 1, 2026
•
3 views
Researchers at BYU are investigating a new immunotechnology called MOTO-CAR, which can genetically engineer immune cells that penetrate solid tumors and attacks the tumor cells.
Source: KSL - Utah | https://www.ksl.com/rss/news - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



